Search
Now showing items 1-6 of 6
Metabolic changes after surgical fat removal: A dose–response meta-analysis
(
Elsevier
, 2023 , Article Review)
BackgroundBariatric surgery averts obesity-induced insulin resistance and the metabolic syndrome. By contrast, surgical fat removal is considered merely an esthetic endeavor. The aim of this article was to establish whether ...
Metabolic changes after nonsurgical fat removal: A dose response meta-analysis
(
Elsevier
, 2023 , Article Review)
BackgroundObesity-induced insulin resistance leads to the metabolic syndrome. Both bariatric surgery and surgical fat removal have been shown to improve metabolic health, but the metabolic benefits of nonsurgical fat removal ...
Angry scientists, angry analysts and angry novelists
(
Springer Nature
, 2023 , Other)
To the Editor: Professor Bonora has written a critique looking back at his career in diabetes research since the 1970s and we reflect on his critique by also looking back at our careers in clinical endocrinology (Professor ...
Metabolic changes after surgical fat removal: Current gaps and suggestions for future studies
(
Elsevier
, 2023 , Other)
Dear Editor,
We read with interest the letter by Seretes et al. discussing the findings and limitations of our evidence synthesis regarding the metabolic implications of surgical subcutaneous fat removal (SSFR).1 It is ...
Development of an evidence-based model for predicting patient, provider, and appointment factors that influence no-shows in a rural healthcare system
(2023 , Article)
Background: No-show appointments pose a significant challenge for healthcare providers, particularly in rural areas. In this study, we developed an evidence-based predictive model for patient no-shows at the Marshfield ...
Pre-prandial plasma liver-expressed antimicrobial peptide 2 (LEAP2) concentration in humans is inversely associated with hunger sensation in a ghrelin independent manner
(
Springer Science and Business Media Deutschland GmbH
, 2023 , Article)
Purpose
The liver-expressed antimicrobial peptide 2 (LEAP2) is a newly recognized peptide hormone that acts via the growth hormone secretagogue receptor (GHSR) blunting the effects of ghrelin and displaying ghrelin-independent ...